Dr. Yoon Jeong Park is currently holding a CTO position at NIBEC and also a professor of Seoul National University. After obtaining Ph.D. degree Pharmaceutics, she moved to US as a research professor in Univ. Michigan, and Principal investigator at ISTN Inc. until 2003. From 2003, she was appointed as professor of Seoul National University, Korea in the field of peptide based drug delivery and biomaterials. She was also appointed as CTO of NIBEC, which is spin-off company from Seoul National University, at 2005. She has published more than 130 scientific peer reviewed journal, 40 international patents, 10 technology transfer experiences and 4) 10 product registration in the field of drug delivery, peptide therapeutics and regenerative biomaterials. Her service as CTO at NIBEC covers in 1) the new drug discovery in the field of cancer, inflammatory disease 2) regenerative biomaterials commercialization and 3) peptide fusion technology in drug and medical device.